Definitive Healthcare (NASDAQ:DH) Updates Q3 2024 Earnings Guidance

Definitive Healthcare (NASDAQ:DH) updated its third quarter 2024 earnings guidance on Tuesday. The company provided earnings per share guidance of 0.070-0.080 for the period, compared to the consensus earnings per share estimate of 0.090. The company issued revenue guidance of $61.0 million-$62.5 million, compared to the consensus revenue estimate of $63.7 million.

Analyst Ratings Changes

A number of research firms recently weighed in on DH. Needham & Company LLC reaffirmed a hold rating on shares of Definitive Healthcare in a research report on Tuesday. Morgan Stanley decreased their target price on shares of Definitive Healthcare from $9.00 to $5.00 and set an equal weight rating for the company in a research report on Tuesday. Canaccord Genuity Group decreased their target price on shares of Definitive Healthcare from $10.00 to $8.00 and set a hold rating for the company in a research report on Wednesday, May 8th. Stifel Nicolaus decreased their target price on shares of Definitive Healthcare from $9.50 to $7.50 and set a buy rating for the company in a research report on Wednesday, July 31st. Finally, Robert W. Baird decreased their target price on shares of Definitive Healthcare from $6.00 to $5.00 and set a neutral rating for the company in a research report on Wednesday. One analyst has rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of Hold and a consensus price target of $7.75.

Definitive Healthcare Stock Performance

DH stock traded up $0.07 during trading hours on Friday, reaching $3.90. The stock had a trading volume of 81,384 shares, compared to its average volume of 821,425. The stock has a market capitalization of $459.95 million, a PE ratio of -2.19, a price-to-earnings-growth ratio of 4.58 and a beta of 1.30. The company has a debt-to-equity ratio of 0.20, a current ratio of 2.30 and a quick ratio of 2.30. The stock has a 50-day simple moving average of $5.34 and a 200 day simple moving average of $6.94. Definitive Healthcare has a fifty-two week low of $3.19 and a fifty-two week high of $11.01.

Definitive Healthcare (NASDAQ:DH) last posted its earnings results on Monday, August 5th. The company reported $0.09 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.09. The company had revenue of $63.70 million during the quarter, compared to analysts’ expectations of $63.19 million. Definitive Healthcare had a negative net margin of 78.16% and a positive return on equity of 0.51%. Definitive Healthcare’s quarterly revenue was up 4.4% compared to the same quarter last year. During the same quarter last year, the company posted $0.08 EPS. Analysts predict that Definitive Healthcare will post 0.09 EPS for the current fiscal year.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.